JUBLPHARMANSEOffline
JUBILANT PHARMOVA · INE700A01033 · Small Cap · #430- Prev close
- 939.55
- Open
- —
- High
- —
- Low
- —
- Volume
- —
- Mkt cap (6-mo avg)
- ₹14,960 cr
Loading minute bars…
NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.
JUBLPHARMA is 20% below its 52-week high, above its 200-day average — a Small Cap company, #430 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice
Overview
What the data says, line by line
A description, never a buy or sell word · tap a line for its detail
How big is it?
six-month average market cap
Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.
Did buyers take delivery?
latest session · 2026-11-05
Price & trend
Returns
to 05 Nov 2026
| Period | Stock | vs Nifty 500 | vs its industry |
|---|---|---|---|
| 1 week | +0.1% | −5.4 pts | — |
| 1 month | −4.3% | −8.5 pts | — |
| 3 months | +2.4% | +4.7 pts | — |
| 6 months | −1.0% | −1.4 pts | — |
| 1 year | −15.3% | −13.1 pts | — |
Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.
Averages & movement
Ownership
Who owns the company
% of all shares, by quarter
| Group | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|
| Promoters | 47.7% | 47.7% | 47.7% | 47.7% |
| FPI | 16.0% | 15.9% −0.1 | 15.9% | 15.4% −0.5 |
| Mutual funds | 7.7% | 8.0% +0.3 | 9.0% +1.0 | 9.4% +0.4 |
| Other DII | 3.5% | 3.6% +0.1 | 3.4% −0.2 | 3.6% +0.2 |
| Individuals | 17.9% | 17.6% −0.3 | 17.2% −0.4 | 17.0% −0.1 |
| Others | 7.3% | 7.2% −0.1 | 6.9% −0.3 | 6.9% |
From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.
Promoter pledge
Sep 26
Holders
Sep 26
Indian passive funds’ stake
2026-06-30
4,76,651 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.
Which funds bought and sold
mutual funds · quarter ended 2026-06-30
| Fund | Shares | Change | Did |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Reg(G)Active | +85,248 | +167.5% | bought |
| Bandhan Small Cap Fund-Reg(G)Active | +12,22,392 | +48.2% | bought |
| Bandhan Focused Fund-Reg(G)Active | +90,000 | +8.6% | bought |
| Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Active | −53,799 | −46.0% | sold |
| Kotak Special Opportunities Fund-Reg(G)Active | −26,000 | −4.1% | sold |
| HDFC NIFTY Smallcap 250 ETFIndex | −787 | −0.8% | sold |
Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.
Mutual-fund schemes, month by month
fund houses’ own monthly portfolios
| Month | Schemes | Bought new | Added | Cut | Sold out | Shares held | Value |
|---|---|---|---|---|---|---|---|
| Sep 26 | 25 | 2 | 6 | 8 | 31 | −2.3% | ₹612 cr |
| Aug 26 | 54 | 5 | 34 | 4 | 0 | +10.7% | ₹537 cr |
| Jul 26 | 49 | 0 | 27 | 10 | 0 | +2.3% | ₹514 cr |
| Jun 26 | 49 | 1 | 28 | 11 | 0 | +2.3% | ₹521 cr |
| May 26 | 48 | 2 | 20 | 14 | 0 | +0.2% | ₹522 cr |
| Apr 26 | 46 | 2 | 30 | 3 | 1 | +2.3% | ₹486 cr |
Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.
Fund ownership is a quarterly disclosure and counts Indian passive schemes only.
Results
Results
Events & filings
Insider trades
SEBI PIT disclosures filed with NSE
| 12 Aug 2025 | SPB Trustee Company Private Limited and SS Trustee Company Private Limited | Promoter Group | Pledge | 20,50,000 | ₹221 cr | 20.08% | Pledge Creation |
| 12 Aug 2025 | HSB Trustee Company Private Limited and HS Trustee Company Private Limited | Promoter Group | Pledge | 20,50,000 | ₹221 cr | 19.00% | Pledge Creation |
| 13 Jun 2025 | Nikita Resources Private Limited | Promoter Group | Sell | 19,62,434 | ₹208 cr | 0.97% | Others |
| 13 Jun 2025 | Jubilant Enpro Private Limited | Promoter Group | Sell | 21,16,000 | ₹224 cr | 0.00% | Others |
| 13 Jun 2025 | SPB Trustee Company Private Limited and SS Trustee Company Private Limited | Promoter Group | Sell | 7,00,000 | ₹74.2 cr | 20.08% | Others |
Sums count buys and sells of equity (market and off-market); pledges are listed but not summed. From NSE’s filings: the archive to 2 May 2026, its XBRL filings since (NSE circular NSE/CML/2026/12). A filing describes what was done, not why.
Disclosures & deals
last six months · NSE filings
- Credit rating22 Oct 2026
- Credit rating15 Oct 2026
- Board outcome12 Oct 2026
- Board outcome11 Aug 2026
- Board outcome25 May 2026
- Board outcome22 May 2026
- Bulk deal: BUY12 Oct 2026
- Bulk deal: SELL12 Oct 2026
- Block deal: BUY12 Oct 2026
- Block deal: SELL12 Oct 2026
Latest shown; 11 in six months on all disclosures.
JUBLPHARMA: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.
Corporate actions
full published history
| Earlier | Dividend | ₹5 | Final | 24 Jul 2026 | 24 Jul 2026 |
| Earlier | Dividend | ₹5 | Final | 25 Jul 2025 | 25 Jul 2025 |
| Earlier | Dividend | ₹5 | Final | 02 Aug 2024 | 02 Aug 2024 |
| Earlier | Dividend | ₹5 | Final | 10 Aug 2023 | 10 Aug 2023 |
| Earlier | Dividend | ₹5 | Final | 11 Aug 2022 | 12 Aug 2022 |
| Earlier | Bonus | 3:5 | — | 12 Mar 2004 | 15 Mar 2004 |
6 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.
Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.